caprolactone has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, AUR; Mo, X; Qin, C; Wang, X; Xu, X; Zhang, W | 1 |
| Bajpai, SK; Chand, N; Soni, S | 1 |
2 other study(ies) available for caprolactone and Alloxan Diabetes
| Article | Year |
|---|---|
Silk fibroin/poly-(L-lactide-co-caprolactone) nanofiber scaffolds loaded with Huangbai Liniment to accelerate diabetic wound healing.
Topics: Animals; Caproates; Diabetes Mellitus, Experimental; Dioxanes; Drugs, Chinese Herbal; Fibroins; Humans; Lactones; Liniments; Mice; Nanofibers; Polyesters; Silk; Tissue Scaffolds; Wound Healing | 2021 |
Controlled release of anti-diabetic drug Gliclazide from poly(caprolactone)/poly(acrylic acid) hydrogels.
Topics: Acetone; Acrylamides; Acrylates; Acrylic Resins; Animals; Caproates; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Gastric Acid; Gliclazide; Glucose; Hydrogels; Hypoglycemic Agents; Intestinal Secretions; Kinetics; Lactones; Models, Molecular; Nitriles; Polyesters; Polymerization; Rats, Wistar; Water | 2015 |